Cosan S.A. Files Form 6-K with SEC

Ticker: CSAN · Form: 6-K · Filed: Nov 4, 2025 · CIK: 1430162

Sentiment: neutral

Topics: sec-filing, 6-K, compliance

Related Tickers: CSAN

TL;DR

Cosan S.A. (CSAN) filed a 6-K on Nov 4, 2025, confirming its reporting status and Brazilian address.

AI Summary

Cosan S.A. filed a Form 6-K on November 4, 2025, reporting material facts as required for foreign private issuers. The filing provides the company's address in São Paulo, Brazil, and confirms it files annual reports under Form 20-F. It also lists its ticker symbols on B3 (CSAN3) and NYSE (CSAN).

Why It Matters

This filing serves as an official notification to investors and regulatory bodies about Cosan S.A.'s compliance and reporting status as a foreign private issuer.

Risk Assessment

Risk Level: low — The filing is a routine disclosure and does not contain new financial information or significant operational updates.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

When was this Form 6-K filed by Cosan S.A.?

This Form 6-K was filed on November 4, 2025.

What are Cosan S.A.'s ticker symbols mentioned in the filing?

Cosan S.A.'s ticker symbols mentioned are CSAN3 on B3 and CSAN on the NYSE.

Where are Cosan S.A.'s principal executive offices located?

Cosan S.A.'s principal executive offices are located at Av. Brigadeiro Faria Lima, 4100, – 16th floor, São Paulo, SP, Brazil.

Does Cosan S.A. file annual reports under Form 20-F or 40-F?

Cosan S.A. files annual reports under cover of Form 20-F.

Filing Stats: 1,120 words · 4 min read · ~4 pages · Grade level 13.6 · Accepted 2025-11-04 06:02:31

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-40155 Cosan S.A. (Exact name of registrant as specified in its charter) N/A (Translation of registrant's name into English) Av. Brigadeiro Faria Lima, 4100, – 16 th floor São Paulo, SP 04538-132 Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F X Form 40-F COSAN S.A. CNPJ nº 50.746.577/0001-15 NIRE 35.300.177.045 Publicly Held Company CVM Code 19836 MATERIAL FACT COSAN S.A. ( B3: CSAN3; NYSE: CSAN ) (“ Cosan ” or the “ Company ”), in compliance with article 157, paragraph 4, of Law No. 6,404, of December 15, 1976, and with Resolution No. 44 of the Brazilian Securities and Exchange Commission (“ CVM ”), of August 23, 2021, and further to the Material Facts disclosed by the Company on September 21, 2025, October 23, 2025 and on this date, hereby informs its shareholders and the market in general that, on this date, the Company has launched a primary offering of its common shares (“ Shares ” and “ Offering ” or “ Second Public Offering ”, respectively) directed (i) in Brazil, exclusively to professional investors, as defined in Article 11 of CVM Resolution No. 30, dated May 11, 2021, who are resident and domiciled or headquartered in Brazil, pursuant to CVM Resolution No. 160, dated July 13, 2022 (“ CVM Resolution 160 ”), (ii) within the United States, to a limited number of qualified institutional buyers, residents and domiciled in the United States of America, as defined in Rule 144A under the U.S. Securities Act of 1933, as amended, (the “ Securities Act ”) promulgated by the U.S. Securities and Exchange Commission (“ SEC ”) pursuant to procedures consistent with, and in reliance on, Section 4(a)(2) of the Securities Act in transactions exempt from, or not subject to, registration under the Securities Act and the rules thereunder, and (iii) outside of the United States and Brazil, to institutional and other investors that are not U.S. persons (as defined in Regulation S of the Securities Act) in reliance on Regulation S under the Securities Act and exemptions from United The Offering will comprise, initially, the issuance of 187,500,000 Shares by the Company, which number may, at the discretion of the Company, in agreement with the placement agents after the bookbuilding process, be increased by up to 53.33% of the total number of Shares initially offered, or 100,000,000 common shares to be issued by the Company, at the same price as the Shares initially offered, to meet any excess demand that may be identified at the time the price per Share is determined. The Second Public Offering will be carried out at the same price per share as the first public offering that the Company announced in the material fact disclosed on October 23rd, 2025, that is, at a fixed price of R$5.00 per Share, which was ratified at the meeting of the Board of Directors approving such first offering. THE COMPANY WILL NOT MAKE AN OFFERING OF ANY AMERICAN DEPOSITARY RECEIPTS REPRESENTING ITS SHARES, AND THE SHARES OFFERED WILL BE SUBJECT TO CERTAIN RESTRICTIONS ON DEPOSIT IN THE AMERICAN DEPOSITARY RECEIPT FACILITY OF THE COMPANY. The completion of the allocation procedure of the Offering is expected to occur on November 11, 2025. Shares purchased in the Offering are expected to begin trading on the São Paulo Stock Exchange (B3 S.A. – Brasil, Bolsa, Balcão) on the second business day after the disclosure of the completion of the allocation procedure, and the settlement of the Offering is expected to occur on the third business day after the completion of the allocation procedure. The Offering of the Shares has not been and will not be registered under the Securities Act, or any other U.S. federal and state securities laws, and the Shares (including any additional Shares, if applicable) may not be offered, sold, pledged or otherwise transferred in the United a registration statement or in transactions exempt from, or not subject to, the registration requirements of the Securities Act. Any information contained herein shall not be taken, transmitted, disclosed, distributed, or disseminated in the United States of America. The distribution of announcements and the offering and sale of securities in certain jurisdictions may be prohibited by law. This material fact is disclosed for informative purpose only and shall not, under any circumstances, be interpreted as, nor constitute, an investment recommendation, or offer to sell, advertise, solicit, or offer to buy or an announcement o

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing